1 Hartkopf AD, "Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer" 147 : 345-351, 2014
2 Molloy TJ, "The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients" 13 : 61-, 2011
3 Bidard FC, "Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer" 21 : 729-733, 2010
4 Benoy IH, "Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer" 94 : 672-680, 2006
5 Hartkopf AD, "Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients : results from a large single-centre analysis" 50 : 2550-2559, 2014
6 Klein CA, "Parallel progression of primary tumours and metastases" 9 : 302-312, 2009
7 Stathopoulou A, "Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer : evaluation of their prognostic significance" 20 : 3404-3412, 2002
8 Fehm T, "HER2 status of circulating tumor cells in patients with metastatic breast cancer : a prospective, multicenter trial" 124 : 403-412, 2010
9 Gebauer G, "Epithelial cells in bone marrow of breast cancer patients at time of primary surgery : clinical outcome during long-term follow-up" 19 : 3669-3674, 2001
10 Nora Dickson M, "Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device" 5 : 34119-, 2011
1 Hartkopf AD, "Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer" 147 : 345-351, 2014
2 Molloy TJ, "The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients" 13 : 61-, 2011
3 Bidard FC, "Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer" 21 : 729-733, 2010
4 Benoy IH, "Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer" 94 : 672-680, 2006
5 Hartkopf AD, "Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients : results from a large single-centre analysis" 50 : 2550-2559, 2014
6 Klein CA, "Parallel progression of primary tumours and metastases" 9 : 302-312, 2009
7 Stathopoulou A, "Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer : evaluation of their prognostic significance" 20 : 3404-3412, 2002
8 Fehm T, "HER2 status of circulating tumor cells in patients with metastatic breast cancer : a prospective, multicenter trial" 124 : 403-412, 2010
9 Gebauer G, "Epithelial cells in bone marrow of breast cancer patients at time of primary surgery : clinical outcome during long-term follow-up" 19 : 3669-3674, 2001
10 Nora Dickson M, "Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device" 5 : 34119-, 2011
11 Gruber I, "Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer" 144 : 353-360, 2014
12 Fischer JC, "Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients" 110 : 16580-16585, 2013
13 Krishnamurthy S, "Detection of minimal residual disease in blood and bone marrow in early stage breast cancer" 116 : 3330-3337, 2010
14 Daskalaki A, "Detection of cytokeratin-19 mRNApositive cells in the peripheral blood and bone marrow of patients with operable breast cancer" 101 : 589-597, 2009
15 Fehm T, "Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells" 11 : 59-, 2009
16 Schindlbeck C, "Comparison of circulating tumor cells(CTC)in peripheral blood and disseminated tumor cells in the bone marrow(DTC-BM)of breast cancer patients" 139 : 1055-1062, 2013
17 Slade MJ, "Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment" 100 : 160-166, 2009
18 Bidard FC, "Clinical validity of circulating tumour cells in patients with metastatic breast cancer : a pooled analysis of individual patient data" 15 : 406-414, 2014
19 Lucci A, "Circulating tumour cells in non-metastatic breast cancer : a prospective study" 13 : 688-695, 2012
20 Franken B, "Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer" 14 : 133-, 2012
21 Cristofanilli M, "Circulating tumor cells, disease progression, and survival in metastatic breast cancer" 351 : 781-791, 2004
22 Rack B, "Circulating tumor cells predict survival in early average-to-high risk breast cancer patients" 106 : 2014
23 Meng S, "Circulating tumor cells in patients with breast cancer dormancy" 10 : 8152-8162, 2004
24 Braun S, "A pooled analysis of bone marrow micrometastasis in breast cancer" 353 : 793-802, 2005
25 Fehm T, "A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation" 107 : 885-892, 2006